Prevention

Latest News

Liquid Biopsy Analysis
LINE-1-ORF1p Is a Promising Biomarker for Early Cancer Detection, But More Research Is Needed

November 22nd 2023

Oncology nurses can help patients understand the potential benefit of ORF1p testing for early cancer detection and its current limitations.

colorectal cancer
Opinion: For Those With Lynch Syndrome, Exercise May Be A Useful Defense Against Colorectal Cancer

October 24th 2023

Mammogram © Tyler Olson - stockadobe.com
Opinion: Cancer Screenings, Although Not Perfect, Remain Valuable

October 18th 2023

FDA Approval
FDA Grants Marketing Authorization to First DNA Test to Assess Multiple Cancer Predispositions

October 4th 2023

On Average, Hispanic Women Are Younger When They Receive A Breast Cancer Diagnosis
On Average, Hispanic Women Are Younger When They Receive A Breast Cancer Diagnosis

September 5th 2023

Latest CME Events & Activities

2023 IASLC North America Conference on Lung Cancer Satellite Symposia

Register Now!

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

Translating New Evidence into Treatment Algorithms from Frontline to R/R Multiple Myeloma: How the Experts Think & Treat

View More

A Focus on Acute Myeloid Leukemia

View More

The Latest on Acute Lymphocytic Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Live “Hot Seat”: Experts Face Your Hot-Button Questions on Maximizing PARP Inhibitors in Patients With CRPC

View More

Show Me the Data™: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed

View More

B-Cell Tumor Board: Rendering Real World Personalized Treatment Plans in CLL/SLL and MCL Through the Lens of Emerging BTKi Evidence

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease

View More

Cancer Summaries and Commentaries™: Clinical Updates from Chicago in Breast Cancer

View More

8th Annual School of Nursing Oncology™

Register Now!

Cancer Summaries and Commentaries™: Clinical Updates in RCC from Chicago

View More

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

More News

© 2023 MJH Life Sciences

All rights reserved.